scholarly journals Persistent Parvovirus B19 Infection without the Development of Chronic Anemia in HIV‐Infected and ‐Uninfected Children: The Women and Infants Transmission Study

2004 ◽  
Vol 189 (5) ◽  
pp. 847-851 ◽  
Author(s):  
Ashley C. LaMonte ◽  
Mary E. Paul ◽  
Jennifer S. Read ◽  
Margaret M. Frederick ◽  
Dean D. Erdman ◽  
...  
Keyword(s):  
Parvovirus B19 ◽  
Chronic Anemia ◽  
Transmission Study ◽  
Parvovirus B19 Infection

Parvovirus B19 Infection Associated with Dilated Cardiomyopathy in Patients with Previous Anthracycline Exposure

2007 ◽  
Vol 28 (5) ◽  
pp. 394-395 ◽  
Author(s):  
C. J. McMahon ◽  
H. Murchan ◽  
T. Prendiville ◽  
M. Burch
Keyword(s):  
Dilated Cardiomyopathy ◽  
Parvovirus B19 ◽  
Parvovirus B19 Infection

Pure red cell aplasia due to parvovirus B19 in a patient treated with rituximab

Blood ◽  
2000 ◽  
Vol 96 (3) ◽  
pp. 1184-1186 ◽  
Author(s):  
Vivek R. Sharma ◽  
Donald R. Fleming ◽  
Stephen P. Slone
Keyword(s):  
Monoclonal Antibody ◽  
B Lymphocytes ◽  
Parvovirus B19 ◽  
Pure Red Cell Aplasia ◽  
Red Cell ◽  
Humoral Immune ◽  
Red Cell Aplasia ◽  
Point Of Interest ◽  
Humoral Immune System ◽  
Parvovirus B19 Infection

Abstract Rituximab is a chimeric monoclonal antibody directed against CD20 and used in the treatment of B-cell non-Hodgkin's lymphoma. Due to its ability to deplete B lymphocytes, rituximab can interfere with humoral immunity, causing it to be suppressed for several months after treatment. The reported case depicts a serious consequence of this effect of rituximab therapy: pure red cell aplasia resulting from chronic parvovirus B19 infection. The point of interest in this case is not only the association between rituximab therapy and pure red cell aplasia, but the diagnostic and therapeutic utility of the knowledge of parvovirus B19 as the likely etiologic link between the two. Given the known efficacy of intravenous immunoglobulin (IVIg) in the treatment of chronic parvovirus B19 infection, this therapy can cure some of these patients and successfully render most others transfusion-independent until recovery of their own humoral immune system.

Human Parvovirus B19 Infection in Patients with Coronary Atherosclerosis

2009 ◽  
Vol 40 (7) ◽  
pp. 612-617 ◽  
Author(s):  
Shih-Chi Liu ◽  
Chia-Ti Tsai ◽  
Cho-Kai Wu ◽  
Meng-Fen Yu ◽  
Mu-Zon Wu ◽  
...  
Keyword(s):  
Coronary Atherosclerosis ◽  
Parvovirus B19 ◽  
Human Parvovirus B19 ◽  
Parvovirus B19 Infection
Sign in / Sign up

Export Citation Format

Share Document